Financial Year |
March 31 2023 |
Monetary Funds |
1,855,252,530.58 |
Held-for-trading Financial Assets |
16,990,000.00 |
Notes Receivable |
139,329,121.18 |
Accounts Receivable |
5,181,056,185.76 |
Advances to Suppliers |
2,310,905,805.39 |
Other Receivables |
892,684,225.93 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
12,341,330,468.75 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
3,917,273,049.06 |
Total Current Assets |
26,698,831,709.36 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
10,128,467,603.28 |
Investment Properties |
549,313,472.94 |
Fixed Assetes |
9,759,072,794.87 |
Under-construction Projects |
106,385,813.87 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
2,346,634,718.53 |
R&D expenses |
270,096,101.52 |
Goodwill |
1,232,146,404.29 |
Long-Term Deferred and Prepaid Expenses |
405,998,871.43 |
Deferred Income Tax Assets |
454,003,188.35 |
Other Non-Current Assets |
23,300,926.60 |
Sub-Total of Non-Current Assets |
25,956,845,620.51 |
Total Assets |
52,655,677,329.87 |
Short-Term Loans |
24,395,375,844.70 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
4,764,658,889.29 |
Accounts Received In Advance |
70,320,214.06 |
Employee Compensation Payable |
288,754,205.52 |
Taxes Payable |
1,595,730,101.95 |
Interest Payable |
41,843,193.45 |
Dividend Payable |
4,885,587.00 |
Other payables |
1,506,039,066.10 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,811,839,504.24 |
Other Current Liabilities |
454,908,845.97 |
Sub-Total of Current Liabilities |
37,344,497,355.06 |
Long-term Loans |
2,482,728,936.00 |
Bonds Payable |
24,000,000.00 |
Long-Term Accounts Payable |
158,975,097.84 |
Special Payable |
-- |
Estimatied Liabilities |
286,245,081.06 |
Deferred Income Tax Liabilities |
181,892,926.85 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
3,947,604,084.13 |
Total Liabilities |
41,292,101,439.19 |
Paid-In Capital(Or Share Stock) |
3,248,913,588.00 |
Capital Surplus |
8,356,793,694.44 |
Surplus Reserve |
496,459,432.38 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-2,835,672,285.48 |
Minority Stockholder's Interest |
2,079,330,054.69 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,284,245,835.99 |
Owner's Equity(Stockholder's Equity) |
11,363,575,890.68 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
52,655,677,329.87 |